Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Current Problems in Cancer|January 11, 2022
CAR T-cell therapy for B-cell lymphomaNathan Denlinger, David Bond, Samantha JaglowskiClinical Lymphoma, Myeloma & Leukemia|April 20, 2024
SOHO State of the Art Updates and Next Questions Updates on Building Your CAR-T Cell ProgramTimothy J Voorhees, Evandro Bezerra, Nathan Denlinger, et al.Transplantation and Cellular Therapy|March 6, 2022
Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell LymphomaAudrey M Sigmund, Nathan Denlinger, Ying Huang, et al.Expert Review of Anticancer Therapy|September 21, 2011
Choosing first-line therapy for chronic lymphocytic leukemiaSamantha Jaglowski, Jeffrey A JonesTransplantation and Cellular Therapy|October 1, 2020
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter AnalysisAdam S Kittai, Ying Huang, Max Gordon, et al.Cancers|August 26, 2022
Recent Advances and Challenges in Cancer ImmunotherapyChelsea Peterson, Nathan Denlinger, Yiping YangFrontiers in Immunology|August 30, 2024
Stem-like CD8<sup>+</sup> T cells in cancerChelsea Steiner, Nathan Denlinger, Xiaopei Huang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2020
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best PracticesMonica Ardura, David Hartley, Christopher Dandoy, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 10, 2019
Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II TrialJoseph Pidala, Samantha Jaglowski, Annie Im, et al.Plos Pathogens|November 7, 2009
A quantitative RNAi screen for JNK modifiers identifies Pvr as a novel regulator of Drosophila immune signalingDavid Bond, Edan FoleyPageof 12